The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer

por Basak, Saroj K., Veena, Mysore S., Oh, Scott, Huang, Ge, Srivatsan, Eri, Huang, Min, Sharma, Sherven, Batra, Raj K.
Publicado 2009

Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells

por Riedl, Karen, Baratelli, Felicita, Batra, Raj K, Yang, Seok Chul, Luo, Jie, Escuadro, Brian, Figlin, Robert, Strieter, Robert, Sharma, Sherven, Dubinett, Steven
Publicado 2003

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

por Baratelli, Felicita, Takedatsu, Hiroko, Hazra, Saswati, Peebles, Katherine, Luo, Jie, Kurimoto, Pam S, Zeng, Gang, Batra, Raj K, Sharma, Sherven, Dubinett, Steven M, Lee, Jay M
Publicado 2008

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

por Sharma, Sherven, Yang, Seok-Chul, Hillinger, Sven, Zhu, Li X, Huang, Min, Batra, Raj K, Lin, Jeff F, Burdick, Marie D, Strieter, Robert M, Dubinett, Steven M
Publicado 2003

The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression

por Basak, Saroj K., Veena, Mysore S., Oh, Scott, Lai, Chi, Vangala, Sitaram, Elashoff, David, Fishbein, Michael C., Sharma, Sanjai, Rao, Nagesh P., Rao, Dinesh, Phan, Ryan, Srivatsan, Eri S., Batra, Raj K.
Publicado 2013

Correction: The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression

por Basak, Saroj K., Veena, Mysore S., Oh, Scott, Lai, Chi, Vangala, Sitaram, Elashoff, David, Fishbein, Michael C., Sharma, Sanjai, Rao, Nagesh P., Rao, Dinesh, Phan, Ryan, Srivatsan, Eri S., Batra, Raj K.
Publicado 2013